According to Heska Corporation 's latest financial reports the company's current EPS (TTM) is S-$2.48. In 2022 the company made an earnings per share (EPS) of S-$2.48 a decrease over its 2021 EPS that were of S-$0.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | S-$2.61 | 4.87% |
2022 | S-$2.48 | 1830% |
2021 | S-$0.13 | -94.19% |
2020 | S-$2.21 | 805.26% |
2019 | S-$0.24 | -123.75% |
2018 | S$1.03 | -43.26% |
2017 | S$1.82 | -9.03% |
2016 | S$2.00 | 93.75% |
2015 | S$1.03 | 81.82% |
2014 | S$0.57 | -309.52% |
2013 | S-$0.27 | -195.45% |
2012 | S$0.28 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | S$14.05 | -665.28% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | S$15.91 | -740.21% | ๐บ๐ธ USA |
![]() Petco WOOF | S-$0.31 | -87.56% | ๐บ๐ธ USA |
![]() Pfizer PFE | S$1.79 | -172.02% | ๐บ๐ธ USA |
![]() Merck MRK | S$8.88 | -457.38% | ๐บ๐ธ USA |
![]() Novartis NVS | S$8.28 | -433.16% | ๐จ๐ญ Switzerland |
![]() Zoetis ZTS | S$7.18 | -389.12% | ๐บ๐ธ USA |